Citigroup
SLS icon

Citigroup’s SELLAS Life Sciences SLS Stock Holding History

Citigroup’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7
Closed -$4K – 7642
2017
Q3 		$4K Buy
+7
New +$4.62K ﹤0.01% 6908
2017
Q1 		– Sell
-7
Closed -$20K – 7324
2016
Q4 		$20K Buy
+7
New +$40.7K ﹤0.01% 6529

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citigroup's SLS Position: Q2 2026 in Review

Citigroup increased its SELLAS Life Sciences (SLS) stake by 1,173% in Q2 2026, buying an estimated $2.08M and bringing the position to 326,591 shares worth $4.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Citigroup first reported a position in SLS in Q4 2016 and has held it in 15 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Citigroup held 326,591 shares of SELLAS Life Sciences worth $4.82M as of Q2 2026.
  • Citigroup bought 300,945 SELLAS Life Sciences shares in Q2 2026, an estimated $2.08M.
  • SELLAS Life Sciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2170 holding.
  • Citigroup first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 15 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.